Senate Democrats have raised new concerns about Health and Human Services Secretary Robert F. Kennedy Jr.’s adherence to an ethics agreement related to a vaccine lawsuit settlement. According to reports from The Hill, a group of Democratic senators questioned whether Kennedy may have concealed an agreement to receive money from a settlement with a vaccine manufacturer, despite pledging to divest from the lawsuit during his confirmation process last year.

During the confirmation hearings, Kennedy was still involved in a lawsuit against a vaccine manufacturer. While he publicly committed to divesting any financial interest in the case, senators now allege that he may have retained a contractual right to collect a portion of the settlement proceeds. The allegation centers on the possibility that Kennedy failed to disclose this arrangement to the Senate Ethics Committee, thereby potentially violating the ethics agreement he signed as part of his confirmation.

The issue matters because it touches on the broader question of conflicts of interest for senior federal officials. If a secretary of a department that regulates vaccines has a financial stake in a settlement with a vaccine manufacturer, questions arise about impartiality in policy decisions. The Senate’s scrutiny reflects ongoing concerns about transparency and accountability within the administration, especially given Kennedy’s controversial history with vaccine advocacy.

Moving forward, the senators have called for a formal review of Kennedy’s financial disclosures and the terms of the settlement agreement. Depending on the outcome, the administration may face pressure to amend the agreement or to provide additional transparency. Kennedy has not yet responded publicly to the accusations, and the Senate Ethics Committee is expected to evaluate the claims in the coming weeks.